Navigation Links
For embolism patients, clot-busting drug is worth risk
Date:2/21/2013

EAST LANSING, Mich. --- When doctors encounter a patient with a massive pulmonary embolism, they face a difficult choice: Is it wise to administer a drug that could save the patient's life, even though many people suffer life-threatening bleeding as a result?

Based on new findings published in the American Journal of Medicine, Michigan State University researchers are answering that question in no uncertain terms.

"The message to doctors is clear: Take the chance," said Paul D. Stein, a professor in MSU's Department of Osteopathic Medical Specialties. "It doesn't matter how old the patient is or what other chronic diseases the patient has. Administering the drug saves lives."

Pulmonary embolism is a potentially deadly blockage of arteries in the lungs caused by blood clots that travel from elsewhere in the body, usually the leg. Clot-dissolving drugs known as thrombolytic agents often can remove the blockage, but they also can cause brain hemorrhages and other major bleeding.

Stein found in an earlier study that only about a third of unstable pulmonary embolism patients -- those who are in shock or require a ventilator -- received thrombolytic therapy, even though the drugs decreased the risk of dying in the hospital from 50 percent to 15 percent.

"Doctors are smart," Stein said, "so why are only a third of patients getting the drug?"

To find out, Stein and Fadi Matta, MSU associate professor of osteopathic medical specialties, reviewed a national database of records from more than 1,000 hospitals. Their findings suggest that concern over the bleeding associated with thrombolytic therapy may keep doctors from giving the drug to patients who could be at higher risk.

In the study, only 20 percent of unstable patients with associated chronic conditions received the drug, compared to 80 percent of those without such conditions. Patients older than 60 also were less likely to receive the treatmen
'/>"/>

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-355-5158
Michigan State University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
2. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or a Heart Attack to Call the Johnson Law Group Now-Before Time Runs Out
3. The US Drug Watchdog Now Warns Time Could Run Out to Get Women Yaz or Yasmin Birth Control Pill Users Identified if they Suffered a Heart Attack Stroke or a Embolism
4. Doctors fail to communicate impact of heart devices with patients, SLU study finds
5. For stroke patients, mechanical clot removal delivers no advantage over standard care
6. TraceLink Life Sciences Cloud Named Amazon AWS Grand Prize Winner for Protecting Patients, Enabling Health, Ensuring Track and Trace Compliance
7. Trauma patients, community say they support exception from informed consent research
8. New Association Created to Advocate for Medical Marijuana Patients, Dispensary Operators and Advocates
9. Doctors Often Miss Signs of Problem Drinking in Patients, Study Finds
10. Get New Patients, INC Releases New Infographic titled 'Are Negative Reviews Killing Your Medical Practice?"
11. Author of the Uplifting Cancer Survival Guide, The C Card and Me, Opens Online Shop with Inspiring Gifts for Cancer Patients, Survivors and Caregivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... TheraBreath is proud to announce a new ... also help with overall health. , Many health experts ... ward off bad bacteria that can cause unwanted infections. While ... own, most will need the help of a probiotic to ... levels. , Packed with the S. salivarius M18 & K12 ...
(Date:3/4/2015)... 2015 Theme and plugin developers from ... for Final Cut Pro X entitled ProFont NoteBook , “ProFont ... any FCPX editors project.” Said Christiana Austin, CEO of Pixel ... add animated font to their FCPX media.” , With ProFont ... within Final Cut Pro X. ProFont Notebook offers users up ...
(Date:3/4/2015)... City View producers are pleased ... vicinity. The city of 90 neighborhoods, each with its own ... for everyone. With many outdoor parks, music and fine ... a metropolitan area everyone should visit once in their lifetime. ... bridges. The stunning cable program will be broadcast on PCNC ...
(Date:3/3/2015)... MA (PRWEB) March 04, 2015 ... educational facilities design and construction event for New ... Boston Massachusetts announced key building envelope related workshops. ... , Workshops include: , Curtain Walls ... in many health care and laboratory facilities are ...
(Date:3/3/2015)... New York (PRWEB) March 03, 2015 ... tactics used to market the atypical antipsychotic medication ... U.S. According to court documents, the South Carolina ... finding that Johnson & Johnson’s Janssen Pharmaceuticals unit ... serious risks. However, while the Court’s February 25th ...
Breaking Medicine News(10 mins):Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2Health News:City View Television Show Will Air in Pittsburgh, PA 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 4Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 5Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 6Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3
... new ... nationwide survey shows, JACKSONVILLE, Fla., Oct. 29 ... on November 4 and see fewer hours of,daylight, findings from a ... may not be seeing while,driving in the dark. Of further concern, ...
... WuXi PharmaTech (NYSE:,WX), China,s premier provider of pharmaceutical ... the company,s Chairman and Chief Executive,Officer received the ... China,2007 Award. This prestigious award was presented to ... 26 in the China World Hotel, Beijing, China. ...
... blood pressure and are at greater risk of hypertension ... quality and exhibit a smaller nighttime decrease in blood ... , This ethnic difference in blood pressure dipping may ... of hypertension, says Dr. Joel Hughes, Kent State assistant ...
... Digital Pen Technology Allows Hospitals, Medical ... PHILADELPHIA, Oct. 29 Today at the ... the,Docuscan Patient Registration system, an innovative solution for ... the chance of data entry errors. With ...
... America how they ,Think About Their Drink, ST. LOUIS, Oct. 29 , ... the Think About Your Drink ... entered the photo contest by submitting a ... part of a nationwide education campaign, ...
... Another disease can be added to the list ... that smoking increases the risk of developing psoriasis, ... risk decreases only slowly after quitting. Investigators from ... the Harvard School of Public Health, all in ...
Cached Medicine News:Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 2Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 3Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 4Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 2Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 3Health News:Pearson Introduces 'Smart' Technology for Collecting Patient Registration Information 2Health News:Pearson Introduces 'Smart' Technology for Collecting Patient Registration Information 3Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 2Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 3Health News:New study shows smoking increases risk of psoriasis 2
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... of the "Telemedicine and Mobile Healthcare Solutions, ... - 2020" report to their offering. ... are all terms that pertain to the use ... provide remote clinical/non-clinical healthcare services. They form the ...
(Date:3/3/2015)... 2015  Cyberonics, Inc. (NASDAQ: CYBX ), ... and management of epilepsy, today announced it will participate ... 11, 2015, in Miami . ... Executive Officer, will speak at 1:05 PM Eastern Time.  ... format, and no formal materials will be presented.  A ...
(Date:3/3/2015)... Today, the Partnership for Prescription Assistance ... research companies, unveiled a redesigned website ... and caregivers with faster, easier access to information ... assistance programs. Since its launch ... engage, educate and empower patients and caregivers to ...
Breaking Medicine Technology:Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 2Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 3Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2
... TAXUS(R) Element(TM) Stent now available in select markets ... (NYSE: BSX ) today announced the ... Coronary Stent System in select markets worldwide. ... chromium alloy engineered specifically for coronary stent applications ...
... Pa., May 18 MEDRAD Interventional(TM)/Possis(R) today announced ... the Paccocath(R) Technology closer to market as an ... the United States and Europe who suffer from ... selection of physician investigators for U.S. clinical trials ...
Cached Medicine Technology:Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 2Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 3Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 4Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 5Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 2Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 3Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 4Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 5
... recommended for evaluating vitreoretinal relationships ... in the management of dislocated ... lens for small pupil fundus ... It provides a slightly wider ...
... new MagPlus Iridectomy Lens enhances iridectomy ... viewing area (than conventional iridectomy lens ... The bulb on this lens has ... lens) to 11.7mm. The MagPlus comes ...
... advanced fundus laser lens design with Volk ... magnification viewing and treatment of the optic ... aspheric optics provide improved performance over existing ... comes standard with LaserWindow® for optimal laser ...
... with 10mm diameter contact surface is ideal ... prematurety (ROP) and other infant conditions. It ... in the diagnosis and treatment of the ... with narrow palpebral fissures. Developed with Hideyuki ...
Medicine Products: